Sixty-six patients with HS were studied before starting a GLP-1 RA medication and again after six months of use
Notably, similar concepts have emerged from studies on metformin, where interindividual variability in therapeutic response and gastrointestinal tolerability has been linked to differences in gut microbiota composition
Semaglutide operates by slowing gastric emptying, allowing your brain to feel fuller quicker, naturally reducing food consumption
The FDA, too, aims to revoke authorization for Citrus Red No
The JAMA study reported a standard deviation of 3.7%, meaning roughly two-thirds of patients fell between 2% and 10% weight loss at three months
New Study Highlights Superiority of Bariatric Surgery Over GLP-1 Medications for Sustained Weight Loss A new real-world study presented at the ASMBS 2025 Annual Meeting compares outcomes between GLP-1 medications (such as semaglutide and tirzepatide) and bariatric surgery